Key result
Men with acute myocardial infarction and type 2 diabetes had significantly higher serum Acetyl-CoA carboxylase activity (25.04 ng/mL) compared to healthy controls (6.12 ng/mL, p≤0.01).
Why the study?
Disordered lipid metabolism characterizes diabetes and increases MI risk, prompting evaluation of the fatty acid synthesis enzyme acetyl-CoA carboxylase in patients with AMI and diabetes.
Case-Control (n=90)
No
Absolute Event Rate: 25.04% vs 6.12%
p-value: p=≤ 0.01
Acetyl-CoA Carboxylase activity is significantly elevated in men with acute myocardial infarction and type 2 diabetes, correlating with adverse lipid and glycemic profiles.
ACC elevation was associated with AMI plus T2DM in men; leaves open whether ACC is a modifiable target.
Background: Acute myocardial infarction (AMI) is a widespread cause of death in numerous parts of the world. Many factors raise the risk of myocardial infarction (MI). One of the most of it is atherosclerosis, caused by many factors such as Hyperlipidemia. Acetyl-CoA carboxylase (ACC) is the key regulatory enzyme in fatty acid synthesis. The disorder of lipid metabolism is one of the characteristics of diabetes, which is considered a risk factor for MI. Therefore, the activity ACC was estimated in patients with AMI and Diabetes. Method: The study included estimation of ACC activity and correlated with other biochemical variables such as Troponin T(cTnT), C-reactive protein (CRP), glucose‚ lipid profile, electrolytes [Sodium (Na⁺), Potassium(K⁺), Chloride (Cl⁻)]‚ urea and creatinine (Crea.), and evaluation of body mass index (BMI) effect in serum of 60 patients with AMI and diabetes compared with 30 serum from apparently healthy individuals as a control group, both groups are of males with an average age (25–60 years). Results and Conclusions: Results showed a significant increase in levels of ACC, cTnT, CRP, Glucose, and Lipid profile except for high-density lipoprotein – cholesterol (HDL-C) and urea, while a significant decrease with Na⁺and K⁺ also a non-significant variation was observed with Cl⁻ and creatinine in AMI and diabetes patients compared to control group.
No takes yet. Share an insight, caveat, or question.
Abdulkareem et al. (2022) conducted a case-control in Acute Myocardial Infarction and Type 2 Diabetes Mellitus (n=90). Acute Myocardial Infarction and Type 2 Diabetes vs. Apparently healthy individuals was evaluated on Acetyl-CoA Carboxylase (ACC) activity (ng/mL) (p=≤ 0.01). Men with acute myocardial infarction and type 2 diabetes had significantly higher serum Acetyl-CoA carboxylase activity (25.04 ng/mL) compared to healthy controls (6.12 ng/mL, p≤0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: